PL3046537T3 - Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego - Google Patents

Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego

Info

Publication number
PL3046537T3
PL3046537T3 PL14851464T PL14851464T PL3046537T3 PL 3046537 T3 PL3046537 T3 PL 3046537T3 PL 14851464 T PL14851464 T PL 14851464T PL 14851464 T PL14851464 T PL 14851464T PL 3046537 T3 PL3046537 T3 PL 3046537T3
Authority
PL
Poland
Prior art keywords
carbohydrates
pharmaceutical preparation
therapeutic use
therapeutic
pharmaceutical
Prior art date
Application number
PL14851464T
Other languages
English (en)
Inventor
Agnes RAFALKO
Tatyana CHERNENKO
Original Assignee
Glycomine, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycomine, Inc. filed Critical Glycomine, Inc.
Publication of PL3046537T3 publication Critical patent/PL3046537T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
PL14851464T 2013-09-16 2014-09-16 Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego PL3046537T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361878591P 2013-09-16 2013-09-16
EP14851464.9A EP3046537B1 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use
PCT/US2014/055921 WO2015053910A2 (en) 2013-09-16 2014-09-16 Pharmaceutical preparation of carbohydrates for therapeutic use

Publications (1)

Publication Number Publication Date
PL3046537T3 true PL3046537T3 (pl) 2022-01-31

Family

ID=52813726

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14851464T PL3046537T3 (pl) 2013-09-16 2014-09-16 Preparat farmaceutyczny węglowodanów do zastosowania terapeutycznego

Country Status (13)

Country Link
US (5) US20160228364A1 (pl)
EP (2) EP3046537B1 (pl)
CY (1) CY1125361T1 (pl)
DK (1) DK3046537T3 (pl)
ES (1) ES2892314T3 (pl)
HR (1) HRP20211564T1 (pl)
HU (1) HUE056624T2 (pl)
LT (1) LT3046537T (pl)
PL (1) PL3046537T3 (pl)
PT (1) PT3046537T (pl)
RS (1) RS62641B1 (pl)
SI (1) SI3046537T1 (pl)
WO (1) WO2015053910A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202192663A1 (ru) * 2019-03-29 2022-03-01 Глайкомайн, Инк. Липосомальные препараты и способы их применения и получения
US11058637B1 (en) * 2020-11-25 2021-07-13 King Abdulaziz University Surface-modified emulsomes for intranasal delivery of drugs
WO2023225102A1 (en) * 2022-05-18 2023-11-23 Glycomine, Inc. Continuous flow methods for producing mannose-1-phosphate, polymorphs of mannose-1-phosphate, and compositions and uses related thereto

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US7189705B2 (en) * 2000-04-20 2007-03-13 The University Of British Columbia Methods of enhancing SPLP-mediated transfection using endosomal membrane destabilizers
US7011845B2 (en) * 2000-05-09 2006-03-14 Mcp Hahnemann University β-glucans encapsulated in liposomes
WO2004103510A2 (en) * 2003-05-14 2004-12-02 The Regents Of The University Of Colorado Methods and apparatus using electrostatic atomization to form liquid vesicles
FR2897779B1 (fr) 2006-02-24 2009-04-17 Orphan Europ Sarl Manossyl-1 phosphates, procede de preparation et utilisation en therapeutique, notamment vis-a-vis dy syndrome cdg-la
JP2011518124A (ja) 2008-03-26 2011-06-23 ユニバーシティ・オブ・オックスフォード 小胞体ターゲッティングリポソーム
US20120135064A1 (en) * 2009-05-27 2012-05-31 Northeastern University Conjugated nanodelivery vehicles
SG181904A1 (en) 2009-12-23 2012-07-30 Novartis Ag Lipids, lipid compositions, and methods of using them
US20110257233A1 (en) 2010-03-19 2011-10-20 Sanford-Burnham Medical Research Institute Benzoisothiazolones as inhibitors of phosphomannose isomerase
WO2012018380A2 (en) * 2010-07-31 2012-02-09 The Scripps Research Institute Compositions and methods for inducing immune tolerance

Also Published As

Publication number Publication date
LT3046537T (lt) 2021-12-10
HRP20211564T1 (hr) 2022-01-21
US20200246266A1 (en) 2020-08-06
US11045419B2 (en) 2021-06-29
EP3046537B1 (en) 2021-07-14
EP3046537A4 (en) 2017-04-19
HUE056624T2 (hu) 2022-02-28
WO2015053910A2 (en) 2015-04-16
CY1125361T1 (el) 2023-03-24
US10449149B2 (en) 2019-10-22
PT3046537T (pt) 2021-10-07
US20160228364A1 (en) 2016-08-11
RS62641B1 (sr) 2021-12-31
US20220110871A1 (en) 2022-04-14
SI3046537T1 (sl) 2022-01-31
EP3046537A2 (en) 2016-07-27
DK3046537T3 (da) 2021-10-11
WO2015053910A3 (en) 2015-06-18
US20180036239A1 (en) 2018-02-08
US20240082155A1 (en) 2024-03-14
EP3954360A2 (en) 2022-02-16
EP3954360A3 (en) 2022-06-01
ES2892314T3 (es) 2022-02-03

Similar Documents

Publication Publication Date Title
IL287516A (en) Medicinal uses of empagliflozin
HRP20190101T1 (hr) Terapeutske uporabe empagliflozina
HK1213818A1 (zh) 依帕列淨的治療用途
PL2981271T3 (pl) Zastosowania terapeutyczne empagliflozyny
SI3228313T1 (sl) Odmerne oblike in terapevtske uporabe L-4-klorokinurenina
ZA201600027B (en) Pharmaceutical preparation
EP2968179A4 (en) RETARD-PRESENTATIONS
LT3046537T (lt) Farmacinis angliavandenių preparatas, skirtas terapiniam panaudojimui
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
EP2984170A4 (en) USE OF ANTIBODY UREASE CONJUGATES FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
ZA201506465B (en) Pharmaceutical preparation
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
GB201319595D0 (en) Combination of Analgesic drugs
GB201316468D0 (en) Combination of analgesic drugs
GB201318230D0 (en) Solutions for administration of pharmaceuticals